Induction of specific cell-mediated immunity in mice by oral immunization with Salmonella expressing Onchocerca volvulus glutathione S- transferase

Vaccine

Volumn 17, Issue 1, 1999, Pages 31-39

  Catmull, Julian ^a   Wilson, Mary E ^a,b   Kirchhoff, Louis V ^b   Metwali, Ahmed ^a   Donelson, John E ^c  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Glutathione S transferase; Onchocerciasis; Oral immunization; Salmonella typhimurium

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; INTERLEUKIN 4; INTERLEUKIN 5; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, HELMINTH; ANTIBODY FORMATION; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; FREUND'S ADJUVANT; GLUTATHIONE TRANSFERASE; IMMUNITY, CELLULAR; IMMUNOBLOTTING; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; SALMONELLA TYPHIMURIUM; SPLEEN; T-LYMPHOCYTES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0032889101     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00147-9     Document Type: Article

References (39)

1. World Health Organisation, 1987. Third report to the expert committee on onchocerciasis. Technical report series No. 752. World Health Organisation, Geneva.
2. Parkhouse R.M.E., Harrison L.J.S. Antigens of parasitic helminths in diagnosis, protection and pathology. Parasitology. 99:1989;S5-S19.
3. Duke B.O.L. Human onchocerciasis-an overveiw of the disease. Acta Leiden. 59:1990;9-24.
4. Ottesen E.A. Immunological aspects of lymphatic filariasis in man. Trans. Roy. Soc. Trop. Med. Hyg. 78:1984;S9-S18.
5. Taylor H.R., Pacque M., Munoz B., Greene B.M. Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science. 250:1990;116-118.
6. Elson L.H., Manuel C.H., Wislon P.Y.et al. Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J. Infect. Dis. 171:1995;652-658.
7. Lange A.M., Yutanawiboonchai W., Scott P., Abraham D. IL-4 and IL-5-dependent protective immunity to Onchocerca volvulus infective larvae in BALB/cBYJ mice. J. Immunol. 153:1994;205-211.
8. Greene B.M., Fanning M.M., Ellner J.J. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. Clin. Exp. Immunol. 52:1983;259-265.
9. MacKenzie C.D., Williams J.F. Variation in clinical presentation in onchocerciasis and their relationship to host-parasite interaction. Sud. Med. J. 21:1985;41-48.
10. Ottesen E.A. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171:1995;659-671.
11. Dafa Alla T.H., Ghalib H.W., Abdelmageed A., Williams J.F. The profile of IgG and IgG subclasses of of onchocerciasis patients. Clin. Exp. Immunol. 88:1992;258-263.
12. McCarthy J.S., Ottesen E.A., Nutman T.B. Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J. Infect. Dis. 170:1994;736-741.
13. Ngu J.L. Immunological studies on onchocerciasis. Varying skin hypersensitivity and leucocyte migration inhibition in a clinical spectrum of the disease. Acta Tropica. 35:1978;269-279.
14. Greene B.M., Gbakima A.A., Albiez E.J., Taylor H.R. Humoral and cellular immune responses to Onchocerca volvulus infection in humans. Rev. Infect. Dis. 7:1985;789-795.
15. Greene B.M., Fanning M.M., Ellner J.J. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus. Clin. Exp. Immunol. 52:1983;259-265.
16. Liebau E., Walter R.D., Henkle-Duhrsen K. Isolation, sequence and expression of an Onchocerca volvulus glutathione S-transferase cDNA. Mol. Biochem. Parasitol. 63:1994;305-309.
17. Lustigman S., Brotman B., Johnson H.E., Smith A.B., Huima T., Prince A.M. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a microfilarial surface-associated antigen. Mol. Biochem. Parasitol. 50:1992;79-94.
18. Balloul J.M., Grzych J.N., Pierce R.J., Capron A. A purified 28 000 Dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J. Immunol. 138:1987;3448-3453.
19. McManus D., Waine G., Wen Y.et al. Towards a vaccine against Asian schistosomiasis. Todays Life Science. 5:1993;24-43.
20. Yang D.M., Fairweather N., Button L.L., McMaster W.R., Kahl L.P., Liew F.Y. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T-helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145:1990;2281-2285.
21. Cesar G., Hone D., Noriega F.R.et al. Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J. Infect. Diseas. 169:1994;927-931.
22. Pistor S., Hobom G. OmpA-haemagglutinin fusion proteins for oral immunization with live attenuated Salmonella. Res. Microbiol. 141:1990;879-881.
23. Prost A. The burden of blindness in adult males in the savanna villages of West Africa exposed to onchocerciasis. Trans. Roy. Soc. Trop. Med. Hyg. 80:1986;525-527.
24. Hoiseth S.K., Stocker B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 291:1981;238-239.
25. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:1983;471-474.
26. Pistor S., Hobom G. Expression of viral hemagglutinin on the surface of E. coli. Klin. Wschr. 66:1988;110-116.
27. Sambrook J, Fritsch EF, Maniatis T, 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbour Laboratory Press, New York, pp. 1.82-1.84.
28. Hattori M., Sakaki Y. Dideoxy sequencing method using denatured plasmid templates. Anal. Biochem. 152:1986;232-238.
29. Grunstein M., Hogness D.S. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc. Natl. Acad. Sci. USA. 72:1975;3961-3965.
30. Harlow E, Lane D, 1988. Antibodies: A Laboratory Manual. Cold Spring Harbour Laboratory, New York, p. 98.
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature. 227:1970;680-685.
32. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
33. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, 1991. Current Protocols in Immunology. John Wiley, New York, pp. 3.12.
34. Xu Y., Macedonis J., Sher A., Pearce E., Cheever A.W. Dynamic analysis of splenic Th1 and Th2 lymphocyte functions in mice infected with Schistosoma japonicum. Infect. Immun. 59:1991;2934-2940.
35. Mosman T.R., Schumacher J.H., Florentino D.F., Leverah J., Moore K.W., Bond M.W. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6 and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay. J. Immunol. 145:1990;2938-2945.
36. Janeway CA, Travers P, 1994. Immunobiology: The Immune System in Health and Disease. Current Biology Ltd/Garland, London, New York.
37. + cytotoxic T cells. J. Exp. Med. 172:1990;1083-1090.
38. Bretscher P.A., Wei G., Menon J.N., Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science. 257:1992;539-542.
39. Beher M.G., Schnaitman C.A., Pugsley A.P. Major heat-modifiable outer membrane protein in Gram-negative bacteria: comparison with OmpA protein of Esherichia coli. J. Bacteriol. 143:1980;906-913.